- Filed
- Feb 4, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Feb 2, 2026 | 52.46M sh |
| Shares Diluted | Q1 2026 · Dec 31, 2025 | 53.65M sh |
| Shares Diluted restated | Q1 2026 · Dec 31, 2024 | 48.67M sh |
| Capex | Q1 2026 · Dec 31, 2025 | $15.2M |
| Capex | Q1 2026 · Dec 31, 2024 | $13.6M |
| Operating Cash Flow | Q1 2026 · Dec 31, 2025 | −$1.26B |
| Operating Cash Flow | Q1 2026 · Dec 31, 2024 | −$477.8M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.59B |
| Cash And Equivalents | Q1 2026 · Sep 30, 2025 | $1.61B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $1.4B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.52B |
| Stockholders Equity | Q1 2026 · Sep 30, 2025 | $2.38B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.78B |
| Stockholders Equity | Q1 2026 · Sep 30, 2024 | $1.71B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $45.26B |
| Total Liabilities | Q1 2026 · Sep 30, 2025 | $42.89B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $47.78B |
| Total Assets | Q1 2026 · Sep 30, 2025 | $45.27B |
| Eps Diluted | Q1 2026 · Dec 31, 2025 | $2.50 |
| Eps Diluted restated | Q1 2026 · Dec 31, 2024 | $1.69 |
| Eps Basic | Q1 2026 · Dec 31, 2025 | $2.66 |
| Eps Basic restated | Q1 2026 · Dec 31, 2024 | $1.77 |
| Net Income | Q1 2026 · Dec 31, 2025 | $139M |
| Net Income | Q1 2026 · Dec 31, 2024 | $85.1M |
| Gross Profit | Q1 2026 · Dec 31, 2025 | $1.44B |
| Gross Profit | Q1 2026 · Dec 31, 2024 | $944.3M |
| Revenue | Q1 2026 · Dec 31, 2025 | $1.2B |
| Revenue | Q1 2026 · Dec 31, 2024 | $663.1M |